Mcrae Inds Cl A (MCRAA) 28.8600 $MCRAA McRae Industries,

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Mcrae Inds Cl A (MCRAA) 28.8600 $MCRAA

McRae Industries, Inc. Reports Earnings For The Third Quarter And First Nine Months Of Fiscal 2015
PR Newswire - Wed Jun 17, 3:30PM CDT
McRae Industries, Inc. (Pink Sheets: MCRAA and MCRAB) reported consolidated net revenues from operations for the third quarter of fiscal 2015 of $25,828,000 as compared to $23,455,000 for the third quarter of fiscal 2014. Net earnings for the third quarter of fiscal 2015 amounted to $1,209,000, or $0.61 per diluted Class A common share as compared to $1,223,000, or $0.61 per diluted Class A common share, for the third quarter of fiscal 2014.

McRae Industries declares dividend of USD0.13 per share
M2 - Thu Jun 04, 10:47AM CDT
McRae Industries Inc (Pink Sheets: MCRAA and MCRAB) announced on Thursday that it will pay a dividend of USD0.13 per share on its Class A and Class B common stock.

McRae Industries declares $0.13 dividend
Seeking Alpha - at Seeking Alpha - Thu Jun 04, 9:10AM CDT


McRae Industries, Inc. Dividend Declared
PR Newswire - Thu Jun 04, 9:00AM CDT
McRae Industries, Inc. (Pink Sheets: MCRAA and MCRAB) declared a dividend of $.13 per share on the Company's Class A and Class B Common Stock payable on July 1, 2015 to shareholders of record on June 17, 2015.

McRae Industries, Inc. Reports Earnings For The Second Quarter And First Six Months Of Fiscal 2015
PR Newswire - Fri Mar 20, 3:30PM CDT
McRae Industries, Inc. (Pink Sheets MCRAA and MCRAB) reported consolidated net revenues for the second quarter of fiscal 2015 of $28,067,000 as compared to $26,604,000 for the second quarter of fiscal 2014. Net earnings for the second quarter of fiscal 2014 amounted to $1,457,000 or $0.71 per diluted Class A common share as compared to net earnings of $1,501,000, or $0.73 per diluted Class A common share, for the second quarter of fiscal 2014.

McRae Industries, Inc. declares $0.13 dividend
Seeking Alpha - at Seeking Alpha - Thu Mar 05, 3:51PM CST


Dan Post Boots/McRae Industries, Inc. Selects CGS's BlueCherry(R) Enterprise Suite to Power their Fundamental Business Processes
PRWeb - Mon Jan 26, 1:01PM CST
CGS, a leading global provider of business applications, enterprise learning and outsourcing services announces that after an extensive evaluation and due diligence process, Dan Post Boots selected CGS's BlueCherry(R) Enterprise Suite to replace the company's existing software to maximize efficiency, enhance the accuracy of decision-making data and gain around-the-clock system support. Dan Post Boots is a wholly owned subsidiary of McRae Industries, whose core businesses is manufacturing military boots for the United States government.

McRae Industries, Inc. Reports Earnings For The First Quarter Of Fiscal 2015
PR Newswire - Mon Dec 15, 4:30PM CST
McRae Industries, Inc. (Pink Sheets: MCRAA and MCRAB) reported consolidated net revenues for the first quarter of fiscal 2015 of $29,239,000 as compared to $31,653,000 for the first quarter of fiscal 2014. Net earnings for the first quarter of fiscal 2015 amounted to $2,347,000, or $1.07 per diluted Class A common share as compared to net earnings of $3,045,000, or $1.33 per diluted Class A common share, for the first quarter of fiscal 2014.

McRae Industries announces dividend of USD0.13 per share
M2 - Mon Dec 08, 4:12AM CST
Footwear company McRae Industries Inc (Pink Sheets:MCRAA) (Pink Sheets:MCRAB) declared on Friday that it will pay a class A and B common stock dividend of USD0.13 per share.

McRae Industries, Inc. Reports Earnings For Fiscal 2014
PR Newswire - Tue Nov 11, 3:30PM CST
McRae Industries, Inc. (Pink Sheets: MCRAA and MCRAB) reported consolidated net revenues for fiscal 2014 of $103,629,000 as compared to $97,071,000 for fiscal 2013. Net earnings for fiscal 2014 totaled $7,548,000 as compared to $7,498,000 for fiscal 2013. Net earnings per diluted Class A common share were $3.51 for fiscal 2014 as compared to $3.79 for fiscal 2013.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Antheia Secures $80M for Critical Medicine Onshoring

Updated Category News Views 42

Antheia's Bold Move to Onshore Medicine Production Folks, when it comes to pharmaceuticals, it's about time someone started serious about keeping things closer to home. Antheia just landed a huge $80 million conditional commitment from the U.S. Department of War's Office of Strategic Capital. The fine print? This isn't just about building business—it's a play to secure...

Continue Reading
AEVEX Facing Class Action: Deadline Looms for Investors

Updated Category News Views 4

The Clock is Ticking for AVEX Investors News flash, folks: If you bought into AEVEX Corp. (NYSE: AVEX) between mid-April and early June this year, you might have a legal gold mine on your hands—or at least a shot to join a class action that could knock some dollars back into your pocket. Mark it on your calendar—October 20, 2026, is the last call to toss your hat in...

Continue Reading
GELITA Showcases Collagen Innovations at SupplySide 2026

Updated Category News Views 7

Collagen Solutions Front and Center First up, a little chat about collagen might be in order. For folks not tied into the science side, it sounds like a trendy wellness potion. But here comes GELITA at SupplySide Global 2026, showing it's the real McCoy. Nestled in Booth #4565, they're laying out a spread of next-gen collagen innovations aimed at everything from wound...

Continue Reading
Venue Two Eleven: Historic Charm Meets Modern Events

Updated Category News Views 5

Welcome To Venue Two Eleven: Where History Meets Modernity Alright, folks. Let’s talk about Venue Two Eleven—a new joint in town that’s blending the old with the new in a way that’s got me raising an eyebrow and maybe even sipping my coffee a little slower. Nestled in the Museum of the Oregon Territory, this place is pulling double duty as both a window to the...

Continue Reading
Richard Huffman Joins IFA Board, Strengthens Franchise Ties

Updated Category News Views 5

Ever wonder how the cogs in this massive machine called franchising keep turning? It's folks like Richard Huffman who step up to the plate, and his recent election to the International Franchise Association (IFA) Board of Directors is worth a second glance. Huffman: A Franchise Veteran Now, Huffman isn't some rookie in the world of franchising. You see, back in '94, he...

Continue Reading
Alpha Rising Joins RFP: A Strong AI-Fueled Expansion

Updated Category News Views 9

The Shift: From LPL to AI-Driven Innovation Hold onto your hats, because Alpha Rising Wealth Management has taken a significant leap from the traditional ship of LPL Financial to the cutting-edge shores of Rothschild Financial Partners (RFP). It's a move that's painting the walls in Scottsdale, Arizona with $250 million in client assets, all set to benefit from a modern,...

Continue Reading
AEVEX Faces 48-Hour Deadline for Investor Class Action

Updated Category News Views 44

Clock Ticking on AEVEX Lawsuit Participation Ah, the twists and turns of the stock market! AEVEX Corp. (NYSE: AVEX) finds itself knee-deep in a class action lawsuit, and investors have a mere 48 hours left to make their stand as the lead plaintiff. This legal saga stems from the company's April 2026 IPO and spills into the muddy waters of securities law violations....

Continue Reading
AAI Rolls Out Agency Gauge: AI-Driven Insights Platform

Updated Category News Views 2

Bringing Artificial Intelligence to the Insurance Table Affordable American Insurance (AAI) is shaking things up in the insurance world with their new tool, Agency Gauge. Picture this: you're running an independent agency, neck-deep in data, and this AI-powered marvel swoops in and turns those confusing numbers into actionable business insights. It's like having a wise...

Continue Reading
U.S. Millionaire Surge: Market Waves or Mirage?

Updated Category News Views 1

Flashing Billions: Minting Millionaires at Breakneck Speed It sounds like something out of an 80s movie: every single day, over 1,200 folks in the United States become millionaires. Yep, you heard right. The UBS Global Wealth Report 2026 threw that number out, and it sure caught my attention. It's not everyday you hear about the U.S. cranking out millionaires like they're...

Continue Reading
UEG's New Advisory Board: Elevating Patient Voices

Updated Category News Views 61

Breaking Ground with Patient Representation Today's not-so-sunny forecast from Barcelona wasn't about the weather. United European Gastroenterology (UEG) rolled out its shiny new Patient Representatives Advisory Board (PRAB) during UEG Week 2026. This isn't just another committee on a never-ending list—it's a serious platform aimed at turning patient murmurs into a...

Continue Reading

Top 5 Most Recently Viewed Articles

Akeso Reports Progress with Ivonescimab in Cancer Treatment

Updated Category News Views 232

Akeso Moves Forward with Promising Cancer Therapy Trials Akeso Biopharma is excited to share fantastic news regarding its latest clinical endeavors in the realm of cancer treatment. The company has successfully enrolled the first patient in the AK112-309 trial, a pivotal Phase III study designed to evaluate the efficacy of ivonescimab in combination with another regimen...

Continue Reading
Quanex Building Products Raises Dividend for Shareholders

Updated Category News Views 168

Quanex Building Products Announces Quarterly Dividend HOUSTON — Quanex Building Products Corporation (NX) is pleased to announce that its Board of Directors declared a quarterly cash dividend of $0.08 per share on its common stock. This dividend is scheduled to be paid to shareholders of record on a specified date, indicating the company's commitment to rewarding its...

Continue Reading
Trump Calls for Transparency from COVID Drug Manufacturers

Updated Category News Views 204

Trump Demands Drug Firms Reveal COVID Vaccine Data Former President Donald Trump has issued a call to pharmaceutical companies to provide concrete evidence regarding the effectiveness of their COVID-19 drugs, particularly emphasizing the need for transparency surrounding their vaccine data. Transparency in Pharmaceuticals On his social media platform, Trump urged these...

Continue Reading
AECOM Technology Sees Stock Surge to Record $108.26 High

Updated Category News Views 106

AECOM Technology Stock Peaks at $108.26 AECOM Technology Corporation has recently achieved a major milestone in the stock market, reaching an impressive high of $108.26. This achievement not only reflects the robust growth of the infrastructure consulting firm but also represents a 43.14% increase in its stock value over the past year. Investors have been showing strong...

Continue Reading
China's Return to US Soybean Purchases Sparks Market Optimism

Updated Category News Views 678

China Resumes U.S. Soybean Purchases Amid Market Changes Recent reports indicate that China has made its initial purchase of U.S. soybeans from the current year’s harvest, marking the end of a prolonged boycott. This significant development comes just ahead of a highly anticipated summit between U.S. President Donald Trump and Chinese President Xi Jinping. Market...

Continue Reading